Navigation Links
GlaxoSmithKline Share Their Insight on Understanding DDI With a View to Better Prediction and Control
Date:6/28/2012

LONDON, June 28, 2012 /PRNewswire/ --

Pharma IQ has released a new interview with Dr. James Clarke, Senior Scientist, GlaxoSmithKline, on the biggest challenges for clinically relevant drug transporters that GSK faces.

In this exclusive podcast Dr. Clarke shares his knowledge on how drug transporters exert a vital influence on drug absorption, disposition, metabolism and elimination and why they are an essential part of predicting drug disposition. He provides ideas on how the current technology landscape changed following the publication of the ITC white paper and the progress we can expect to see in clinically relevant drug transporters.

This interview was created as a part of the pre-conference research for the 3rd Annual Clinically Relevant Drug Transporters, taking place from the 22nd- 24th  October, 2012 in London.

The interview helped to shape the summit agenda which features among others - Eva Gil Berglund, PhD, Medical Products Agency, Sweden and Keith Hoffmaster, Senior Investigator from Novartis (ITC member) who provide an insight into new developments in the FDA / EMA transporter interaction Draft Guidance Papers.

Other important topics which will be discussed at the event include:

  • Model-based Prediction of Transporter-mediated Disposition and DDIs (Manthena Varma, Principle Scientist, Pfizer)
  • Drug Targeting: how can we use Uptake Transporters to achieve CNS or Tumour Penetration  (Maarten Huisman, Janssen Pharmaceutical Companies)
  • De-risking conjugated metabolites for causing transporter DDI with toxicological implications (Timothy Shultz - Utermoehl, Shire Pharmaceuticals)
  • Impact of "transporter-metabolism" and "transporter-transporter" interplay in Raloxifene Disposition (Jae Chang, Research Scientist, Genentech)

Press are invited to attend this important industry forum. If you would like to a complimentary press pass please email Joanna Checinska (joanna.checinska@iqpc.co.uk)

To access Dr. James Clarke's full interview or find out more about the Clinically Relevant Drug Transporters Summit please visit http://www.drugrtransporters/news, email enquire@iqpc.co.uk or call +44(0)207-930-1300.

Media contact: Joanna Checinska, +44(0)20-7368-9807, joanna.checinska@iqpc.co.uk  - Please contact for more information or images.


'/>"/>
SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Employees Embark on Long-Term Volunteer Assignments throughout the World
2. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
3. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
4. Telemedicine Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
5. Heska Announces Quarterly Dividend of $0.10 Per Share
6. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
7. OncoSec Medical Issues Letter to Shareholders
8. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
9. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
10. Omnyx Share Their Insight on Agile Software Development for Medical Devices
11. Faruqi & Faruqi, LLP is Investigating Pain Therapeutics Inc. on Behalf of its Shareholders (PTIE)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
Breaking Medicine News(10 mins):